Living dangerously: How helicobacter pylori survives in the human stomach

Nature Reviews Molecular Cell Biology

Volumn 2, Issue 6, 2001, Pages 457-466

  Montecucco, Cesare ^a,b   Rappuoli, Rino ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b CHIRON VACCINES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; STOMACH; STOMACH DISEASE;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH; STOMACH DISEASES;

EID: 0035374653     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/35073084     Document Type: Review

References (101)

1. Warren, J. R. & Marshall, B. J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1, 1273-1275 (1983). The beginning of a Copernican revolution in gastroenterology, which has led to a complete change of perspective and therapeutic approach with a tremendous improvement of human health.
2. Achtman, M. & Suerbaum, S. (eds) Helicobacter pylori: Molecular and Cellular Biology (Horizon Scientific, Norfolk, 2001). The most updated multi-author book covering the molecular and tissue mechanisms of action of H. pylori virulence factors.
3. Parsonnet, J. The incidence of Helicobacter pylori infection. Aliment. Pharmacot. Ther. 9, suppl. 2, 45-51 (1995).
4. Covacci, A., Telford, J. L., Del Giudice, G., Parsonnet, J. & Rappuoli, R. Helicobacter pylori virulence and genetic geography. Science 284, 1328-1333 (1999).
5. Donati, M. De Medica Historia Mirabili (Mantua, 1586).
6. Go, M. F. What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? Gastroenterol. 113, S15-S20 (1997).
7. Marshall, B. J. & Langton, S. R. Urea hydrolysis in patients with Campylobacter pyloridis infection. Lancet 26, 965-966 (1986).
8. Hu, L.-T. & Mobley, H. L T. Purification and N-terminal analysis of urease from Helicobacter pylori. Infect. Immun. 58, 992-998 (1990).
9. Labigne, A., Cussac, V. & Courcoux, P. Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity. J. Bacteriol. 173, 1920-1931 (1991).
10. Jabri, E., Carr, M. B., Hausinger, R. P. & Karplus, P. A. The crystal structure of urease from Klebsiella aerogenes. Science 268, 998-1004 (1995).
11. Bauerfeind, P., Garner, R., Dunn, B. E. & Mobley, H. L. Synthesis and activity of Helicobacter pylori urease and catalase at low pH. Gut 40, 25-30 (1997).
12. +-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science 287, 482-485 (2000). A remarkable paper on how this bacterium handles the vital urea molecule.
13. Phadnis, S. H. et al. Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires. bacterial autolysis. Infect. Immun. 64, 905-912 (1996).
14. Dunn, B. E. et al. Localization of Helicobacter pylori urease and heat shock protein in human gastric biopsies. Infect. Immun. 65, 1181-1188 (1997).
15. Eaton, K. A., Brooks, C. L. Morgan, D. R. & Krakowka, S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect. Immun. 59, 2470-2475 (1991).
16. Clyne, M., Labigne, A. & Drumm, B. Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect. Immun. 63, 1669-1673 (1995).
17. Megraud, F., Neman-Simha, V. & Brugman, D. Further evidence of the toxic effect of ammonia produced by Helicobacter pylori urease on human epithelial cells. Infect. Immun. 60, 1858-1863 (1992).
18. Suzuki, M. et al. Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury. Am. J. Physiol. 263. G719-G725 (1992).
19. Sommi, P. et al. Significance of ammonia in the genesis of gastric epithelial lesions induced by Helicobacter pylori: an in vitro study with different bacterial strains and urea concentrations. Digestion 57, 299-304 (1996).
20. Williams, C. L., Preston, T., Hossack, M., Slater, C. & McColl, K. E. Helicobacter pylori utilizes urea for amino acid synthesis. FEMS Immunol. Med. Microbiol. 13, 87-94 (1996).
21. Harris, P. R., Mobley. H. L., Perez-Perez, G. I., Blaser, M. J. & Smith, P. D. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterol. 111, 419-425 (1996).
22. Ferrero, R. L., Thiberge, J.-M., Huerre, M. & Labigne, A. Recombinant antigens prepared from the urease subunits of Helicobacter pylori spp: evidence of protection in a mouse model of gastric infection. Infect. Immun. 62, 4981-1989 (1994).
23. Del Giudice, G., Covacci, A., Telford, J. L. Montecucco, C. & Rappuoli, R. The design of vaccines against Helicobacter pylori and their development. Annu. Rev. Immunol. 19, 523-563 (2001). A thorough and updated analysis of the current status of the effort to produce an anti H. pylori vaccine.
24. Josenhans, C. & Suerbaum, S. in Helicobacter pylori: Molecular and Cellular Biology (eds Achtman, M. & Suerbaum, S) 171-184 (Horizon Scientific, Norfolk, UK, 2001).
25. Yoshiyama, H., Nakamura, H., Kimoto, M., Okita, K. & Nakazawa, T. Chemotaxis and motility of Helicobacter pylori in a viscous environment. J. Gastroenterol. 34, suppl. 11, 18-23 (1999).
26. Slomiany, B. L. & Slomiany, A. Role of mucus in gastric mucosal protection. J. Physiol. Pharmacol. 42, 147-161 (1991).
27. Lichtenberger, L. M. The hydrophobic barrier properties of gastrointestinal mucus. Annu. Rev. Physiol. 57, 565-583 (1995).
28. Bhaskar, K. R. et al. Viscous fingering of HCI through gastric mucin. Nature 360, 458-461 (1992).
29. Slomiany, B. L., Murty, V. L. Piotrowski, J. & Slomiany, A. Gastroprotective agents in mucosal defense against Helicobacter pylori. Gen. Pharmacol. 25, 833-841 (1994).
30. Boren, T., Falk, P., Roth, L. A., Larson, G. & Normark, S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262, 1892-1895 (1993).
31. Ilver, D. et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279, 373-377 (1998).
32. Evans, D. G., Karjalainen, T. K., Evans, D. J., Graham, D. Y. & Lee, C.-H. Cloning, nucleotide sequence, and expression of a gene encoding an adhesion subunit protein of Helicobacter pylori. J. Bacteriol. 175, 674-683 (1993).
33. Jones, A. C. et al. A flagellar sheath protein of Helicobacter pylori is identical to HpaA, a putative N-acetylneuraminyllactose-binding hemagglutinin, but is not an adhesin for AGFS cells. J. Bacteriol. 179, 5643-5647 (1997).
34. Tomb, J. F. et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388, 539-547 (1997). Although H. pylori is the most recent bacterial pathogen discovered, its genome was one of the first to be sequenced. The genome sequence provides a fundamental step in the understanding of H. pylori.
35. Alm, R. A. et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397, 176-180 (1999).
36. Valkonen, K., Wadstrom, T. & Moran, A. P. Identification of the N-acetylneuraminyllactose-speafic laminin binding protein. Infect. Immun. 65, 916-923 (1993).
37. Lingwood, C. A. et al. Receptor affinity purification of a lipid-binding adhesin from Helicobacter pylori. Infect. Immun. 61, 2474-2478 (1993)
38. Namavar, F., Sparrius, M., Veerman, E. C. I., Appelmelk, B. J. & Van Vandenbroucke-Grauls, C. M. Neutrophil-activating protein mediates adhesion of Helicobacter pylori to sulphated carbohydrates on high-molecular weight salivary mucin. Infect. Immun. 66, 444-447 (1997).
39. Odenbreit, S. et al. Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue. Mol. Microbiol. 31, 1537-1543 (1999).
40. Edwards, N. J. et al. Lewis X structures in the O antigen side-chain promote adhesion of Helicobacter pylori to the gastric epithelium. Mol. Microbiol. 35, 1530-1539 (2000).
41. Smoot, D. T. et al. Adherence of Helicobacter pylori to cultured human gastric epithelial cells. Infect. Immun. 61, 350-355 (1993).
42. Segal, E. D., Falkow, S. & Tompkins, L. S. Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins. Proc. Natl Acad. Sci. USA 93, 1259-1264 (1996).
43. Marshall, B. J., Armstrong, J. A., McGeche, D. B. & Glancy, R. J. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med. J. Austr. 142, 436-439 (1985). A classic of medical microbiology.
44. Fiocca, R. et al. Epithelial cytotoxicity, immune responses, and inflammatory components of Helicobacter pylori gastritis. Scand. J. Gastroenterol. 205, 11-21 (1994).
45. Dixon, M. F., Genta, R. M., Yardley, J. H. & Correa, P. Classification and grading of gastritits. The updated Sidney System. Am. J. Surg. Pathol. 20, 1161-1181 (1996).
46. Yoshida, N. et al. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 105, 1431-1440 (1993).
47. Evans, D. J. Jr et al. Characterization of a Helicobacter pylori neutrophit-activating protein. Infect. Immun. 63, 2213-2220 (1995).
48. Satin, B. et al. The neutrophil activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor J. Exp. Med. 191, 1467-1476 (2000). An accurate characterization of the mode of activation and chemotaxis induced by HP-NAP, including the first demonstration that HP-NAP is a major antigen.
49. Montemurro, P. et al. HP-NAP of Helicobacter pylori alters the coagulation-fibrinolysis balance of human blood mononudear cells by stimulating the expression of Tissue Factor and PAI-2. J. Infect. Dis. 183, 1055-1062 (2001).
50. Crabtree, J. E. et al. Induction of interleukin-8 secretion from gastric epithelial cells by cagA negative isogenic mutant of Helicobacter pylori. J. Clin. Pathol. 48, 967-969 (1995).
51. Shimoyama, T., Everett, S. M., Dixon, M. F., Axon, A. T. R. & Crabtree, J. E. Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori positivity and severity of gastritis. J. Clin. Pathol. 51, 765-770 (1998).
52. Cover, T. L. & Blaser, M. J. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem. 267, 10570-10575 (1992). The original description of the VacA toxin.
53. Salama, N., Otto, G., Tompkins, L. & Falkow, S. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect. Immun. 69, 730-736 (2001). An almost textbook example of insightful study of bacterial ecology.
54. McClain, M.S., Cao, P. & Cover, T. L. Amino-terminal hydrophobic region of Helicobacter pylori vacuolating cytotoxin (VacA) mediates transmembrane protein dimerization. Infect. Immun. 69, 1181-1184 (2001).
55. Telford, J. L et al. Gene structure of Helicobacter pylori cytotoxin and evidence of a key role in gastric disease. J. Exp. Med. 179, 1653-1658 (1994).
56. Atherton, J. C. et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific VacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270, 17771-17777 (1995).
57. Pagliaccia, C. et al. The m2 form of the Helicobacter pylori cytotoxin has cell-type-specific vacuolating activity. Proc. Natl Acad. Sci. USA 95, 10212-10217 (1998).
58. McClain, M. S., Schraw, W., Ricci, V., Boquet, P. & Cover, T. L. Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells. Mol. Microbiol. 37, 433-442 (2000).
59. Szabo, I. et al. Formation of anion-setective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J. 18, 5517-5527 (1999).
60. Tombola, F. et al. Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers. Biophys. J. 76, 1401-1409 (1999).
61. Iwamoto, H., Czajkowsky, D. M., Cover, T. L., Szabo, G. & Shao, Z. VacA from Helicobacter pylori: a hexameric chloride channel. FEBS Lett. 450, 101-104 (1999).
62. Lupetti, P. et al. Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J. Cell. Biol. 133, 801-807 (1996).
63. de Bernard, M. et al. Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J. Biol. Chem. 270, 23937-23940 (1995).
64. Yahiro, K. et al. Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta. J. Biol. Chem. 274, 36693-36699 (1999).
65. Cover, T. L., Hanson, P. I. & Heuser, J. E. Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating toxin, reveals its pattern of assembly. J. Cell Biol. 138, 759-769 (1997).
66. Eaton, S. & Simons, K. Apical, basal, and lateral cues for epithelial polarization. Cell 82, 5-8 (1995).
67. Papini, E. et al. Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J. Clin. Invest 102, 813-820 (1998).
68. Pelicic, V. et al. Helicobacter pylori VacA cytotoxin associated with bacteria increases epithelial permeability independently of its vacuolating activity. Microbiology 145, 2043-2050 (1999).
69. de Bernard, M., Moschioni, M., Napolitani, C., Rappuoli, R. & Montecucco, C. The VacA toxin of Helicobacter pylori identifies a new intermediate filament interacting protein. EMBO J. 19, 48-56 (2000).
70. Hotchin, N. A., Cover, T. L. & Akhtar, N. Cell vacuolation induced by the VacA cytotoxin of Helicobacter pylori is regulated by the Rad GTPase. J. Biol. Chem. 275, 14009-14012 (1999).
71. Ricci, V. et al. Helicobacter pylori vacuolating toxin accumulates within the endosomal-vacuolar compartment of cultured gastric cells and potentiates the vacuolating activity of ammonia. J. Pathol., 183, 453-459 (1997).
72. Molinari, M. et al. Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers. J. Biol. Chem. 272, 25339-25344 (1997).
73. Papini, E. et al. The vacuolar ATPase proton pump is present on intracellular vacuoles induced by Helicobacter pylori. J. Med. Microbiol. 44, 1-6 (1996).
74. Papini, E. et al. The small GTP binding protein rab7 is essential for cellular vacuolation induced by Helicobacter pylori cytotoxin. EMBO J. 16, 15-24 (1997). The demonstration that VacA induced cell vacuolization is a specific process requiring the enzymic activity of a specific Rab protein involved in the control of membrane transport at the late endosomal level.
75. - channel isoform that limits the rate of endosomal acidification by providing the counter-anion necessary for electric balance.
76. Tombola, F. et al. Inhibition of the vacuolating and anion activities of the VacA toxin of Helicobacter pylori. FEBS Lett. 460, 221-225 (1999).
77. De Bernard, M. et al. Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosol. Mol. Microbiol. 26, 665-674 (1997).
78. Ye, D., Wiiihite, D. C. & Blanke, S. R. Identification of the minimal intracellular vacuolating domain of the Helicobacter pylori vacuolating toxin. J. Biol. Chem. 274, 9277-9282 (1999).
79. Galmiche, A. et al. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J. 19, 6361-6370 (2000).
80. Molinari, M. et al. Selective inhibition of Li-dependent antigen presentation by Helicobacter pylon toxin VacA. J. Exp. Med. 187, 135-140 (1998).
81. D'Elios, M. M. et al. Th1 effector specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158, 962-967.
82. + cytotoxic T cell response and prolongs viral infection. J. Infect. Dis. 177, 72-80 (1998).
83. Satin, B. et al. Vacuolating toxin of Helicobacter pylori inhibits maturation of procathepsin D and degradation of epidermal growth factor in HeLa cells through a partial neutralization of acidic intracellular compartments. J. Biol. Chem. 272, 25022-25028 (1997).
84. Censini, S. et al. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl Acad. Sci. USA 93, 14648-14653 (1996). The demonstration that virulent H. pylori contain a 40-kb foreign DNA (called pathogenicity island or PAI) coding for a type IV secretion system represented a milestone in the understanding of H. pylori pathogenesis and provided an explanation for the presence of the cagA gene only in a subset of strains. Also see reference 95.
85. Hacker, J. & Kaper, J. B. Pathogenicity islands and the evolution of microbes. Annu. Rev. Microbiol. 54, 641-679 (2000).
86. Ogura, K. et al. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J. Exp. Med. 192, 1601-1610 (2000).
87. Perez-Perez, G. I. et al. The role of CagA status in gastric and extragastric complications of Helicobacter pylori. J. Physiol. Pharmacol. 50, 833-885 (1999).
88. Personnel, J. et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori strains. Gut 40, 297-301 (1997).
89. Webb, P. M., Crabtree, J. E. & Forman, D. Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori and serum pepsinogens: an international study, the Eurogast Study Group. Gastroenterology 116, 269-276 (1999).
90. Christie, P. J. & Vogel, J. P. Bacterial type IV secretion: conjugation systems adapted to effector molecules to host cells. Trends Microbiol. 8, 354-360 (2000).
91. Asahi, M. et al. Helicobacter pylori CagA protein delivered into the gastric epithelial cells can be tyrosine phosphorylated. J. Exp. Med. 191, 593-602 (2000).
92. Segal, E. D., Cha, J., Lo, J., Falkow, S. & Tompkins, L. S. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl Acad. Sci. USA 96, 14559-14564 (1999).
93. Stein, M., Rappuoli, R. & Covacci, A. Tyrosine phosphorylation of Helicobacter pylori CagA after cag-driven host translocation. Proc. Natl Acad. Sci. USA 97, 1263-1268 (2000).
94. Odenbrait, S. et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287, 1497-1500 (2000). References 91-94 each independently reported this unique and novel finding in bacterial pathogenesis. A bacterial protein (CagA) is introduced by a specialized secretion system (type IV secretion) into the host cell, which tyrosine phosphorylates the bacterial protein and initiates a cascade of events, which ultimately led to tissue damage and decrease.
95. Covacci, A. et al. Molecular characterization of the 128-KDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl Acad. Sci. USA 90, 5791-5795 (1993).
96. Naumann, M. et al. Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. J. Biol. Chem. 274, 31655-31662 (1999).
97. 2 in epithelial cells. J. Biol. Chem. 276, 804-810 (2001).
98. Covacci, A. & Rappuoli, R. Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cells. J. Exp. Med. 191, 587-592 (2000).
99. Rappuoli, R. et al. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol. Today 20, 493-500 (1999).
100. Ermark, T. H. et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med. 188, 2277-2288 (1998).
101. Solnick, J. V. & Schauer, D. B. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin. Microbiol. Rev. 14, 59-97 (2001).